Live Breaking News & Updates on Chemoembolization Tace

Stay updated with breaking news from Chemoembolization tace . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

TACE Plus Durvalumab and Bevacizumab Could Alter SOC in Embolization-Eligible, Unresectable HCC

Riccardo Lencioni, MD, discusses how TACE, durvalumab, and bevacizumab, could represent a new standard of care in embolization-eligible HCC. ....

Italy , Riccardo-lencioni , Department-of-surgery , Cancers-symposium , Critical-area-pathology , Riccardo-lencioni , D , Chemoembolization-tace- , Urvalumab-imfinzi- , Nd-bevacizumab-avastin- , Hepatocellular-carcinoma , Hcc